UBS Maintains a 'Buy' on ACE Ltd (ACE); Solid Results with Better Outlook
Get Alerts ACE Hot Sheet
Price: $111.02 +0.87%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS maintains a 'Buy' on ACE Ltd (NYSE: ACE), raises PT from $69 to $73.
UBS analyst says, "Underlying 2011 guidance up slightly – more optimistic on top line growth: ACE now guides for 2011 EPS of $5.40–$5.70 (prior $6.10–$6.50). Excl. loss reserve releases and catastrophe losses, the new EPS guidance calls for $7.22–$7.52, up from prior $6.97-$7.37. ACE grew more optimistic about its top line growth in 2011 (sees high-single to low-double digit growth, not including any price firming following recent cat losses). We are raising our 2011E EPS to $6.50 primarily due to higher investment income and better results in the life segment. Our 2012E EPS is now $7.45, up from prior $7.40."
For more ratings news on ACE Ltd click here and for the rating history of ACE Ltd click here.
Shares of ACE Ltd closed at $66.47 yesterday.
UBS analyst says, "Underlying 2011 guidance up slightly – more optimistic on top line growth: ACE now guides for 2011 EPS of $5.40–$5.70 (prior $6.10–$6.50). Excl. loss reserve releases and catastrophe losses, the new EPS guidance calls for $7.22–$7.52, up from prior $6.97-$7.37. ACE grew more optimistic about its top line growth in 2011 (sees high-single to low-double digit growth, not including any price firming following recent cat losses). We are raising our 2011E EPS to $6.50 primarily due to higher investment income and better results in the life segment. Our 2012E EPS is now $7.45, up from prior $7.40."
For more ratings news on ACE Ltd click here and for the rating history of ACE Ltd click here.
Shares of ACE Ltd closed at $66.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Neutral Rating on Gentex (GNTX) Ahead of Investor Day
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share